直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
  • 最新情報
  • Finneganについて
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • プロボノ活動
  • 事務所運営管理
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

High Court Arguments on Patent Attorneys’ Fees Focus on ‘Objective Unreasonableness’

February 26, 2014

On Wednesday, February 26, Finnegan partner Donald R. Dunner appeared before the U.S. Supreme Court to represent respondent Allcare in a case concerning “exceptional” patent case determinations when awarding attorney fees. Allcare advocated for that the Federal Circuit not defer to district courts in patent-related appeals. In argument, Dunner acknowledged that while the Federal Circuit judges may not always agree, it is still a single tribunal focused on patent law. “You have lots of dissenting opinions, concurring opinions,” he said, “but it’s a single body, and a single body that has jurisdiction over all the cases is better situated.”

When the argument turned to questions of law, Dunner again referred to legislative intent that the Federal Circuit establish uniformity in patent appeals. Neither side may find a “perfect” answer, “But there’s a best answer,” Dunner said, “and I suggest that the best answer is to let the legal issues decided by the court that gets tons of patent issues, that has a lot more experience—as Justice Alito mentioned in one of the points that he made—rather than district court judges who may get a few cases, may get a lot of cases, depending what district you're in.”

Related News

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP